Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Wesana Health Holdings Inc. (C:WESA)

Business Focus: Biotechnology & Medical Research

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for WESA within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Sep 14, 2021 07:30 ET
Wesana Health Commits Funding of $1.5 Million To Support MAPS’ Research Pipeline
Wesana Health Holdings Inc.  (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), an emerging data-driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and...
Read full article
Sep 09, 2021 07:30 ET
Wesana Health Announces Closing of PsyTech Acquisition
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and...
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
0.75
--
--
Price to Sales - TTM
--
16.90
10.38
Price to Book - most recent quarter
3.22
3.92
3.26
Price to Cash Flow per share - TTM
--
11.33
13.33
Price to Free Cash Flow per share - TTM
--
18.02
31.14
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Aug 31, 20213,640-2,405
Aug 15, 20216,0452,898
Jul 31, 20213,147-17,374
See Short Report

Business Summary

Sector:  Healthcare Industry:  Biotechnology & Medical Research

Wesana Health Holdings Inc, formerly Debut Diamonds Inc. (Debut), is a Canada-based life science company. The Company is engaged in development and delivery of psychedelic and naturally sourced therapies to treat traumatic brain injury (TBI) and related conditions. It develops evidence-based formulations and protocols for patients to overcome neurological, psychological and mental health ailments caused by trauma.

See business summary

 

Twitter

Search (past week) for $WESA.CA

  • No tweets found